A personal essay published by The Daily Wire has drawn attention to concerns about standard practices in fertility medicine, with the author arguing she was pushed toward in vitro fertilization without receiving thorough diagnostic testing for underlying conditions.
The account describes a woman who spent over a decade following what she described as a healthy lifestyle before struggling to conceive. After undergoing standard fertility tests including hormone panels, genetic testing, and imaging studies at an IVF clinic, she said she received a diagnosis of "unexplained infertility" and was told IVF was her only path forward based on her age of 31.
She wrote that she later consulted with a doctor practicing Restorative Reproductive Medicine, a field that emphasizes identifying and treating root causes of infertility rather than immediately routing patients toward assisted reproduction. Following a diagnostic laparoscopy, the essay states she was found to have a blocked fallopian tube, stage one endometriosis, a cervical cyst, and fibroids—conditions her initial workup did not detect.
The author argued that women are being asked to advocate for medical tests beyond what they can reasonably be expected to know to request. "How is a patient supposed to know what 'extensive enough' looks like?" she wrote.
What the Right Is Saying
Conservative commentators and some medical professionals argue that standard fertility medicine prioritizes technology over investigation. They point to Restorative Reproductive Medicine as an alternative approach that seeks to diagnose and treat underlying conditions such as endometriosis, fibroids, and hormonal imbalances before recommending expensive assisted reproduction procedures.
Senators including James Lankford of Oklahoma have raised concerns about the lack of diagnostic thoroughness in some fertility clinics, arguing that patients deserve comprehensive evaluation before being presented with IVF as their only option. The senator has supported legislation promoting informed consent standards in reproductive medicine.
"Women are being told this is their only path without anyone actually looking at what's underneath," said a spokesperson for the Family Policy Alliance. "Restorative Reproductive Medicine offers hope to couples who want to address root causes rather than simply bypass them."
Some conservative groups have also raised ethical concerns about IVF, including embryo destruction and selective reduction practices. The Charlotte Lozier Institute has published research questioning whether patients are fully informed of all options before proceeding with assisted reproduction.
What the Left Is Saying
Democratic health policy advocates generally support expanding insurance coverage for fertility treatments including IVF, arguing that high costs create barriers to family formation. Groups such as RESOLVE: The National Infertility Association have pushed for legislation requiring private insurers and Medicaid to cover diagnostic testing and assisted reproduction.
Progressive critics of the essay's framing note that unexplained infertility is a legitimate medical diagnosis affecting approximately 10-30% of couples struggling with conception, and that IVF remains an evidence-based treatment with established success rates. They argue that directing patients toward alternative medicine approaches without robust clinical evidence risks delaying effective treatment and wasting valuable time, as female fertility declines significantly after age 35.
Representative Barbara Lee and other Democratic lawmakers have sponsored legislation to mandate fertility preservation coverage for cancer patients and expand access to IVF services. The party's platform emphasizes reproductive autonomy—supporting a woman's right to make her own healthcare decisions including pursuing assisted reproduction without financial barriers.
"Every family deserves the freedom to build their family in the way that works best for them, whether that's through adoption, fertility treatments, or other means," Lee wrote in a statement supporting the Family Building Equity Act.
What the Numbers Show
According to data from the Society for Assisted Reproductive Technology (SART), approximately 326 fertility clinics operated in the United States as of 2024, performing roughly 400,000 IVF cycles annually. The average cost of a single IVF cycle ranges from $12,000 to $25,000, with most patients requiring multiple attempts.
The CDC reports that live births resulting from IVF have increased steadily, with approximately 2% of all infants born in the United States now conceived through assisted reproduction technology. Success rates vary significantly by age, ranging from roughly 40-50% for women under 35 to below 10% for women over 42.
A 2021 study published in Frontiers in Endocrinology followed nearly 2,700 women with Polycystic Ovarian Syndrome (PCOS) undergoing IVF and found that approximately 25% developed ovarian hyperstimulation syndrome during treatment. The research highlighted elevated risks associated with certain pre-existing conditions.
RESOLVE estimates that roughly one-third of infertility cases involve female factors, one-third involve male factors, and the remaining cases involve both partners or unexplained causes. Diagnostic testing for conditions such as endometriosis typically requires surgical procedures not always included in standard fertility workups.
Insurance coverage remains uneven across states. According to the Kaiser Family Foundation, 22 states plus Washington D.C. have enacted laws requiring some level of infertility treatment coverage, though scope and eligibility requirements vary widely.
The Bottom Line
The personal account has amplified existing debates about transparency and thoroughness in fertility medicine. Patients, advocates, and some medical professionals argue that standard diagnostic protocols may miss treatable conditions before routing patients toward expensive assisted reproduction procedures.
Medical organizations including the American Society for Reproductive Medicine maintain that IVF represents a well-established, evidence-based treatment with documented success rates. They note that unexplained infertility is a real diagnosis where comprehensive testing has not identified an underlying cause amenable to targeted treatment.
State legislatures in multiple regions are considering measures that would expand fertility treatment coverage requirements and informed consent standards. Federal legislation on fertility care access remains under discussion as reproductive health policy continues to evolve.
Those experiencing infertility are encouraged to seek second opinions and ask detailed questions about diagnostic alternatives before committing to expensive treatment protocols, regardless of which political perspective they find most compelling.